Did you know that the camera sensor in your smartphone could help unlock the secrets of antimatter? The AEgIS collaboration, ...
A Connecticut-based financial services company has been named the No. 2 best place to work in the United States, according to a new Fortune survey.Synchrony, a Stamford-based finance and insurance ...
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...
HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.
The Power Of Love scored Huey Lewis and the News their first number one and an Oscar nod but as Hayes remembers it he just ...
The non-profit Institute for Clinical and Economic Review has issued a lukewarm final evidence report on Vertex ...
2d
Pharmaceutical Technology on MSNVertex halts development of diabetes cell therapy after trial failureVertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
The ASX took a hit on tariff fears with markets dropping globally. Gold soared to new highs and eyes turn to the RBA’s rate ...
ASX tanks on "Liberation Day" worries with gold hitting records, while iron ore, tech stocks, and Qantas take a hit.
Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...
Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results